All In Biotech

Drug Trial Radar · NCT03094403

To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel

A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Azeliac Acid Gel and Active Treatments to a Placebo Control in the Treatment of Moderate Facial Rosacea.

Last checked: Nov 19, 2026Latest source record: Apr 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,000 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,000

Actual

Start

Jul 1, 2016

Primary completion

Mar 31, 2017

Study completion Apr 1, 2017

Sponsor

Sponsor type
Industry
First posted
Mar 29, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study

Conditions

  • Rosacea

Interventions

  • Azelaic Acid 15% topical gelDrug

    Gel

  • Finacea® (azelaic acid) Gel, 15%Drug

    Gel

  • PlaceboDrug

    Gel

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in inflammatory lesion countsTime frame: 12 weeks

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.